[go: up one dir, main page]

EP0673559A1 - Motor system with individually controlled redundant windings - Google Patents

Motor system with individually controlled redundant windings

Info

Publication number
EP0673559A1
EP0673559A1 EP94903543A EP94903543A EP0673559A1 EP 0673559 A1 EP0673559 A1 EP 0673559A1 EP 94903543 A EP94903543 A EP 94903543A EP 94903543 A EP94903543 A EP 94903543A EP 0673559 A1 EP0673559 A1 EP 0673559A1
Authority
EP
European Patent Office
Prior art keywords
windings
motor
winding
synchronized
control means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94903543A
Other languages
German (de)
French (fr)
Inventor
Robert H. Hoel
Zygmut Zubkow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Honeywell Inc
Original Assignee
Honeywell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Honeywell Inc filed Critical Honeywell Inc
Publication of EP0673559A1 publication Critical patent/EP0673559A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K16/00—Machines with more than one rotor or stator
    • H02K16/04—Machines with one rotor and two stators
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K29/00—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices
    • H02K29/06—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices with position sensing devices

Definitions

  • This invention relates generally to brushless DC motor systems.
  • the invention relates to a brushless DC motor system especially adapted for use in high reliability uses where redundancy is essential, such as in thrust vector control of rocket engines.
  • Thrust vector control of rocket engines has in the past been primarily accomplished with the use of hydraulic actuators.
  • Hydraulic actuators employing hydraulic pumps while commonly in use, have a disadvantage in that they require high- maintenance costs and suffer from low reliability. More particularly, hydraulic pumps typically run at full speed thereby requiring operation of the hydraulic system controlling the rocket engine to operate at continuous maximum power. Other disadvantages include the fact that they require use of dangerous materials such as hydrazine and are generally very messy due to the presence of hydraulic fluid over the parts.
  • Alternative approaches to hydraulic actuators have involved the use of electromagnetic actuators. In comparison to hydraulic systems, electromagnetic actuator systems use much less energy, with a typical hydraulic actuator system using over 34 times as much energy during a mission as a comparable electromagnetic actuator system.
  • DC brushless motors are available in several configurations from open loop controlled multi-toothed propelled drives called stepping motors to inside permanent magnet rotor and outside permanent magnet rotor closed loop machines. Due to their wide range of performance and motion control capabilities, such motors are theoretically particularly desirable for use in applications such as rocket vector control, for example, in controlling the direction of orientation of rocket motor nozzles. However, such motors have not been used widely in the field of rocket nozzle control because in the event of shorting of the winding of the motor, the system could experience a catastrophic failure due to the inability to move the DC brushless motor, which locks up upon the shorting of a winding. As may be appreciated, such a failure in the motor can result in a complete and catastrophic failure of the rocket mission.
  • the permanent magnet motor system includes a shaft for having multiple permanent magnets mounted thereon, and with the shaft rotatably mounted for rotation about a central axis thereof.
  • the permanent magnets are mounted along a predetermined length of the shaft, substantially around the circumference thereof, for causing the shaft to rotate as a result of an inductive force being applied to the permanent magnets.
  • At least three windings, each electrically isolated from each other, are arranged around the permanent magnets, each for being individually electrically excited to generate an induction field. The field generated causes the shaft to rotate as a result of the interaction between the generated field and the permanent magnets.
  • Individual winding controllers for example, pulse width modulation controller chips, individually control each of the windings in a manner such that should there be a short in one of the windings, the other two windings continue to generate the necessary fields to (1) continue to drive the shaft in a rotational motion, and (2) overcome the drag created by the shorted winding.
  • the motor system is fault tolerant taking into account, in a DC brushless motor arrangement, the possible shorting of a winding thereof.
  • the windings are preferably arranged in a Y-winding configuration with each of the winding legs parallel to the others. Such a configuration is conventional and well known to those of ordinary skill in the art.
  • the winding controllers are insulated gate bipolar transistor power modules.
  • the windings comprise at least three windings and more preferably, at least eight. As may be appreciated, in the case with eight windings, should one winding short, the motor will still retain 3/4 of its power due to the loss of one winding by shorting, and another winding being dedicated to overcoming the drag of the winding that shorted. In the case of a single winding shorting in a three winding arrangement, 1/3 power is retained.
  • a sensor or sensors are arranged for detecting the rotational position of the shaft.
  • the sensor or sensors provide a signal to a motor controller, which controls the insulated gate bipolar transistor power modules of the windings, to issue a control signal to the power modules to excite the windings to cause the shaft to be rotated into a desired position.
  • Figure 1 is a schematic diagram of the control circuit architecture and winding arrangement for a DC brushless motor system in accordance with the invention.
  • Figure 2 is a second schematic diagram showing the control modules of Figure 1 connected to a motor controller, and with the motor shaft having a position sensor thereon.
  • the fault tolerant winding control system in accordance with the invention, is designated generally by the reference number 1 1.
  • a single common shaft 13 is shown illustrated in association with redundant windings 17 arranged in a Y configuration about the shaft.
  • the shaft 13 includes permanent magnets
  • the windings 17 are connected in a manner to be individually and separately electrically excited to generate a field which interacts with the magnets to cause the shaft 13 to rotate.
  • Each winding 17 has three legs, 19a, 19b, and 19c, which are arranged in a conventional and well known Y configuration.
  • each winding 17 is shown individually controlled by a respective control module 21.
  • These modules 21 are, for example, insulated gate bipolar transistor power modules.
  • the other redundant windings 17, which are each individually and separately controlled by the power modules 21 through insulated gate bipolar transistors 23a, 23b and 23c, continue to drive the shaft 13 of the motor.
  • modules 21 they are conventional and well known to those of ordinary skill in the art. Examples of such commercially available modules include the PWR-82331 high current three-phase bridge power hybrid. Details of such a module are disclosed in the publication by ILC Data Device Corporation PWR-282331 Smart Power Three-Phase Bridge. 1989, which disclosure is incorporated by reference herein.
  • a motor controller 27 is employed to control the power modules 21 such that they are synchronized to ensure that the magnets are acted upon by the fields generated by individual windings 17 in a synchronized manner.
  • a motor controller 27 is employed.
  • Such a controller 27 is conventional and well known and can take the form of, for example, a programmable logic array (PLA).
  • PPA programmable logic array
  • position sensors 29 can be mounted on the shaft 13 to detect the position of the shaft 13 relative to where it has been commanded by motor controller 27 to be located.
  • the position detection sensors 29 provide a position signal to motor controller 27 wherein it is compared to a reference to result in an error signal.
  • the error signal is then processed by the controller 27 to generate a signal to the control modules 21 to cause the shaft 19 to be rotated to the desired position correcting for the error until the error signal generated is equal to null.

Landscapes

  • Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Permanent Magnet Type Synchronous Machine (AREA)
  • Brushless Motors (AREA)

Abstract

A fault tolerant brushless DC motor includes plural parallel windings (17), each individually controlled by a respective control module (21). At least three windings are provided such that in the event there is a short in one of the windings, the other two windings continue to generate a field to cause the shaft (13) of the motor, having permanent magnets (15) mounted thereon, to rotate. Preferably at least three windings (17) are provided such that in the event of a single short, one of the remaining two windings serves to nullify the drag generated by the shorted winding with the other remaining winding generating a sufficient field to cause the shaft (13) of the motor to rotate. The motor system has particular application in a field of vector control of rocket nozzles. In a preferred configuration, the system includes eight windings (17).

Description

MOTOR SYSTEM WITH INDIVIDUALLY CONTROLLED REDUNDANT WINDINGS
FIELD OF THE INVENTION This invention relates generally to brushless DC motor systems. In particular, the invention relates to a brushless DC motor system especially adapted for use in high reliability uses where redundancy is essential, such as in thrust vector control of rocket engines.
BACKGROUND OF THE INVENTION
Thrust vector control of rocket engines has in the past been primarily accomplished with the use of hydraulic actuators. Hydraulic actuators employing hydraulic pumps, while commonly in use, have a disadvantage in that they require high- maintenance costs and suffer from low reliability. More particularly, hydraulic pumps typically run at full speed thereby requiring operation of the hydraulic system controlling the rocket engine to operate at continuous maximum power. Other disadvantages include the fact that they require use of dangerous materials such as hydrazine and are generally very messy due to the presence of hydraulic fluid over the parts. Alternative approaches to hydraulic actuators have involved the use of electromagnetic actuators. In comparison to hydraulic systems, electromagnetic actuator systems use much less energy, with a typical hydraulic actuator system using over 34 times as much energy during a mission as a comparable electromagnetic actuator system. Other advantages resulting from the use of electromagnetic actuator systems is that they are very rugged and require low maintenance. Further, installation of such devices is extremely simple and testing of such systems can be accomplished prior to launch of a rocket using either external or internal battery power. In this regard, the past three basic approaches for motors in electromagnetic actuator systems used in rocket nozzle control have been considered. Specifically, the systems considered in the past are "switched reluctance", "AC induction" and "DC brushless motors".
DC brushless motors are available in several configurations from open loop controlled multi-toothed propelled drives called stepping motors to inside permanent magnet rotor and outside permanent magnet rotor closed loop machines. Due to their wide range of performance and motion control capabilities, such motors are theoretically particularly desirable for use in applications such as rocket vector control, for example, in controlling the direction of orientation of rocket motor nozzles. However, such motors have not been used widely in the field of rocket nozzle control because in the event of shorting of the winding of the motor, the system could experience a catastrophic failure due to the inability to move the DC brushless motor, which locks up upon the shorting of a winding. As may be appreciated, such a failure in the motor can result in a complete and catastrophic failure of the rocket mission.
Thus, to date, as an alternative to the above noted hydraulic systems, there has been proposed the use of AC induction motors. Such systems are desirable in that AC induction motors will typically not lock up upon the shorting of a winding, but have the disadvantages that AC induction motor control electronics are highly complex and the torque/speed characteristics of such motors vary greatly and do not provide the precise control desired for rocket nozzles. Accordingly, in accordance with the invention, there is proposed a DC brushless motor system which suffers none of the disadvantages of hydraulic and AC motor systems while overcoming the previously recognized catastrophic failure possibilities. More particularly, there is disclosed herein a DC brushless motor system which is fault tolerant to windings shorting when in operation.
SUMMARY OF THE INVENTION In accordance with one aspect of the invention there is provided a permanent magnet motor system. The permanent magnet motor system includes a shaft for having multiple permanent magnets mounted thereon, and with the shaft rotatably mounted for rotation about a central axis thereof. The permanent magnets are mounted along a predetermined length of the shaft, substantially around the circumference thereof, for causing the shaft to rotate as a result of an inductive force being applied to the permanent magnets. At least three windings, each electrically isolated from each other, are arranged around the permanent magnets, each for being individually electrically excited to generate an induction field. The field generated causes the shaft to rotate as a result of the interaction between the generated field and the permanent magnets. Individual winding controllers, for example, pulse width modulation controller chips, individually control each of the windings in a manner such that should there be a short in one of the windings, the other two windings continue to generate the necessary fields to (1) continue to drive the shaft in a rotational motion, and (2) overcome the drag created by the shorted winding. Thus, the motor system is fault tolerant taking into account, in a DC brushless motor arrangement, the possible shorting of a winding thereof.
The windings are preferably arranged in a Y-winding configuration with each of the winding legs parallel to the others. Such a configuration is conventional and well known to those of ordinary skill in the art. Preferably, the winding controllers are insulated gate bipolar transistor power modules. In a preferred arrangement, the windings comprise at least three windings and more preferably, at least eight. As may be appreciated, in the case with eight windings, should one winding short, the motor will still retain 3/4 of its power due to the loss of one winding by shorting, and another winding being dedicated to overcoming the drag of the winding that shorted. In the case of a single winding shorting in a three winding arrangement, 1/3 power is retained. In a more specific aspect of the invention, a sensor or sensors are arranged for detecting the rotational position of the shaft. The sensor or sensors provide a signal to a motor controller, which controls the insulated gate bipolar transistor power modules of the windings, to issue a control signal to the power modules to excite the windings to cause the shaft to be rotated into a desired position. These and other features and advantages of the invention will be more readily apparent upon reading the following detailed description of the invention, made with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic diagram of the control circuit architecture and winding arrangement for a DC brushless motor system in accordance with the invention; and
Figure 2 is a second schematic diagram showing the control modules of Figure 1 connected to a motor controller, and with the motor shaft having a position sensor thereon.
DETAILED DISCUSSION
Referring to Figure 1 , the fault tolerant winding control system, in accordance with the invention, is designated generally by the reference number 1 1. A single common shaft 13 is shown illustrated in association with redundant windings 17 arranged in a Y configuration about the shaft. The shaft 13 includes permanent magnets
15 mounted about the length thereof and about the circumference of the shaft 13. The windings 17 are connected in a manner to be individually and separately electrically excited to generate a field which interacts with the magnets to cause the shaft 13 to rotate. Each winding 17 has three legs, 19a, 19b, and 19c, which are arranged in a conventional and well known Y configuration.
In Figure 1, each winding 17 is shown individually controlled by a respective control module 21. These modules 21 are, for example, insulated gate bipolar transistor power modules. Thus, should a winding 17 be shorted, the other redundant windings 17, which are each individually and separately controlled by the power modules 21 through insulated gate bipolar transistors 23a, 23b and 23c, continue to drive the shaft 13 of the motor.
As may be appreciated, in order to achieve fault tolerant operation, there should be at least three windings 17, and preferably eight (as generally designated by the solid arrow showing an extension of shaft 13). Thus, the loss of one winding 17 due to shorting, in the case of three, results in a motor having at least 1/3 of its original drive power, and in the case of eight windings, a loss of only 1 /4 of its power.
With respect to the modules 21, they are conventional and well known to those of ordinary skill in the art. Examples of such commercially available modules include the PWR-82331 high current three-phase bridge power hybrid. Details of such a module are disclosed in the publication by ILC Data Device Corporation PWR-282331 Smart Power Three-Phase Bridge. 1989, which disclosure is incorporated by reference herein. To control the power modules 21 such that they are synchronized to ensure that the magnets are acted upon by the fields generated by individual windings 17 in a synchronized manner, a motor controller 27 is employed. Such a controller 27 is conventional and well known and can take the form of, for example, a programmable logic array (PLA). As shown in Figure 2, to ensure more precise operation of the motor, position sensors 29 can be mounted on the shaft 13 to detect the position of the shaft 13 relative to where it has been commanded by motor controller 27 to be located. In such a case, the position detection sensors 29 provide a position signal to motor controller 27 wherein it is compared to a reference to result in an error signal. The error signal is then processed by the controller 27 to generate a signal to the control modules 21 to cause the shaft 19 to be rotated to the desired position correcting for the error until the error signal generated is equal to null.
Modification and variations of the present invention are possible in light of the above teachings. It is therefore understood that within the scope of the appended claims, the invention may be practiced other than as specifically described.

Claims

What is claimed is:
1. A brushless DC motor system, comprising: a single shaft rotatably mounted for rotation about a central axis thereof; a plurality of permanent magnets mounted along a length of and substantially about the circumference of said single shaft; at least three individually electrically excitable windings, said at least three windings for generating an induction field for interaction with said plurality of permanent magnets to cause said single shaft to rotate about said central axis, each winding individually electrically isolated from the other windings; and at least three synchronized individual control means, each individual control means connected to a corresponding winding of said at least three individually electrically excitable windings, said at least three synchronized individual control means for synchronized individual control of said corresponding windings such that each corresponding winding generates an induction field in a synchronized manner.
2. A system according to claim 1, wherein each of said at least three individually electrically excitable windings are arranged in a y configuration, and wherein each of said at least three synchronized individual control means include at least three insulated gate bipolar transistor power modules.
3. A system according to claim 1, wherein said at least three individually electrically excitable windings include eight sets of windings, each set arranged in a y configuration, and wherein said at least three synchronized control means includes eight insulated gate bipolar transistor power modules.
4. A system according to claim 1 , further comprising: position detecting means for detecting the rotational position of said single shaft and generating a signal indicative of said rotational position; and motor controller means for receiving said signal indicative of said rotational position and for generating a control signal to said at least three synchronized individual control means for exciting said at least three windings to cause said single shaft to rotate to a desired rotational position.
EP94903543A 1992-12-14 1993-12-09 Motor system with individually controlled redundant windings Withdrawn EP0673559A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99224292A 1992-12-14 1992-12-14
US992242 1992-12-14
PCT/US1993/011956 WO1994014226A1 (en) 1992-12-14 1993-12-09 Motor system with individually controlled redundant windings

Publications (1)

Publication Number Publication Date
EP0673559A1 true EP0673559A1 (en) 1995-09-27

Family

ID=25538089

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94903543A Withdrawn EP0673559A1 (en) 1992-12-14 1993-12-09 Motor system with individually controlled redundant windings

Country Status (4)

Country Link
EP (1) EP0673559A1 (en)
JP (1) JPH08504559A (en)
RU (1) RU95114435A (en)
WO (1) WO1994014226A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108945485A (en) * 2017-05-17 2018-12-07 通用电气公司 Propulsion system for aircraft

Families Citing this family (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929549A (en) * 1998-04-02 1999-07-27 Pacific Scientific Company Fault tolerant electric machine
US6437529B1 (en) 1998-05-04 2002-08-20 Comair Rotron, Inc. Multi-stator motor with independent stator circuits
DE19856647B4 (en) * 1998-12-09 2007-03-01 Canders, Wolf-R., Prof. Dr.-Ing. Electric high-torque motor
EP1262687B1 (en) * 2001-06-01 2009-03-25 IHI Aerospace Co., Ltd. Electromotive actuator and method for controlling the same
DE60215095T2 (en) * 2001-09-19 2007-05-10 Parker-Hannifin Corp., Cleveland Motor drive and system
US6819017B2 (en) 2002-01-02 2004-11-16 Intel Corporation Method and apparatus for fan redundancy
US6700266B2 (en) * 2002-01-02 2004-03-02 Intel Corporation Multiple fault redundant motor
US6724183B2 (en) 2002-01-02 2004-04-20 Intel Corporation Method and apparatus for detecting bearing failure
US6791209B2 (en) 2002-01-02 2004-09-14 Intel Corporation Power and control for power supply fans
US7583063B2 (en) 2003-05-27 2009-09-01 Pratt & Whitney Canada Corp. Architecture for electric machine
EP2505649A1 (en) 2006-05-05 2012-10-03 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of GCGR
ES2386578T3 (en) 2006-05-05 2012-08-23 Isis Pharmaceuticals, Inc. Compounds and procedures to modulate PCSK9 expression
US7443642B2 (en) 2006-05-26 2008-10-28 Pratt & Whitney Canada Corp. Electric motor control
GB0613941D0 (en) 2006-07-13 2006-08-23 Pml Flightlink Ltd Electronically controlled motors
DK2410054T4 (en) 2006-10-18 2020-02-10 Ionis Pharmaceuticals Inc Antisense Compounds
US7605503B2 (en) 2007-03-28 2009-10-20 General Electric Company Fault-tolerant permanent magnet machine with reconfigurable stator core slot opening and back iron flux paths
US7605504B2 (en) 2007-03-28 2009-10-20 General Electric Company Fault-tolerant permanent magnet machine with reconfigurable stator core slot flux paths
US7541705B2 (en) 2007-03-28 2009-06-02 General Electric Company Fault-tolerant permanent magnet machine with reconfigurable flux paths in stator back iron
DE102007048642A1 (en) * 2007-10-10 2009-04-16 Mtu Aero Engines Gmbh Electric drive, in particular for a fuel metering unit for an aircraft engine
US8222221B2 (en) 2008-06-04 2012-07-17 The Board Of Regents Of The University Of Texas System Modulation of gene expression through endogenous small RNA targeting of gene promoters
JP2011529686A (en) 2008-07-29 2011-12-15 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Selective inhibition of polyglutamine protein expression
EP2447274B1 (en) 2008-10-24 2017-10-04 Ionis Pharmaceuticals, Inc. Oligomeric compounds and methods
US8476798B2 (en) 2008-11-28 2013-07-02 Pratt & Whitney Canada Corp. Tandem electric machine arrangement
WO2010091308A2 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
EP2421972A2 (en) 2009-04-24 2012-02-29 The Board of Regents of The University of Texas System Modulation of gene expression using oligomers that target gene regions downstream of 3' untranslated regions
GB2462940B8 (en) * 2009-09-03 2012-03-28 Protean Holdings Corp Electric motor and electric generator.
US8749192B2 (en) 2009-09-03 2014-06-10 Protean Electric Limited Electric motor and electric generator
US20110110860A1 (en) 2009-11-02 2011-05-12 The Board Of Regents Of The University Of Texas System Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter
WO2011085271A2 (en) 2010-01-08 2011-07-14 Isis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
US9574191B2 (en) 2010-02-03 2017-02-21 The Board Of Regents Of The University Of Texas System Selective inhibition of polyglutamine protein expression
EP3208347B1 (en) 2010-02-08 2019-08-14 Ionis Pharmaceuticals, Inc. Selective reduction of allelic variants
EP3561060A1 (en) 2010-02-08 2019-10-30 Ionis Pharmaceuticals, Inc. Selective reduction of allelic variants
US9127033B2 (en) 2010-04-28 2015-09-08 Isis Pharmaceuticals, Inc. 5′ modified nucleosides and oligomeric compounds prepared therefrom
US9156873B2 (en) 2010-04-28 2015-10-13 Isis Pharmaceuticals, Inc. Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom
EP2601204B1 (en) 2010-04-28 2016-09-07 Ionis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
US20130156845A1 (en) 2010-04-29 2013-06-20 Alnylam Pharmaceuticals, Inc. Lipid formulated single stranded rna
KR20180026798A (en) 2010-04-29 2018-03-13 아이오니스 파마수티컬즈, 인코포레이티드 Modulation of transthyretin expression
US8957200B2 (en) 2010-06-07 2015-02-17 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011156202A1 (en) 2010-06-08 2011-12-15 Isis Pharmaceuticals, Inc. Substituted 2 '-amino and 2 '-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
EP3031920B1 (en) 2010-07-19 2019-08-21 Ionis Pharmaceuticals, Inc. Modulation of dystrophia myotonica-protein kinase (dmpk) expression
JP5577506B2 (en) 2010-09-14 2014-08-27 ソーラテック コーポレイション Centrifugal pump device
FR2967310B1 (en) 2010-11-04 2013-08-02 Xap ELECTROMAGNETIC MOTOR WITHOUT BRUSH
CA2817960C (en) 2010-11-17 2020-06-09 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
WO2012109395A1 (en) 2011-02-08 2012-08-16 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising bicyclic nucleotides and uses thereof
JP5969979B2 (en) 2011-03-28 2016-08-17 ソーラテック コーポレイション Rotation drive device and centrifugal pump device using the same
CA2831915C (en) 2011-04-01 2021-01-12 Isis Pharmaceuticals, Inc. Modulation of signal transducer and activator of transcription 3 (stat3) expression
DE102011016336A1 (en) 2011-04-07 2012-10-11 Airbus Operations Gmbh High-lift system for an aircraft
CA2832972C (en) 2011-04-13 2019-04-30 Isis Pharmaceuticals, Inc. Antisense modulation of ptp1b expression
EA029137B1 (en) 2011-04-21 2018-02-28 Ионис Фармасьютикалз, Инк. Modulation of hepatitis b virus (hbv) expression
CN103547271A (en) 2011-04-27 2014-01-29 Isis制药公司 Modulation of apolipoprotein CIII (APOCIII) expression
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
CA2838984A1 (en) 2011-06-10 2012-12-13 Isis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
EP2721156B1 (en) 2011-06-16 2016-12-21 Ionis Pharmaceuticals, Inc. Antisense modulation of fibroblast growth factor receptor 4 expression
WO2013003808A1 (en) 2011-06-29 2013-01-03 Isis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
EP3556859B1 (en) 2011-08-11 2021-04-07 Ionis Pharmaceuticals, Inc. Selective antisense compounds and uses thereof
EP3453761A1 (en) 2011-08-29 2019-03-13 Ionis Pharmaceuticals, Inc. Oligomer-conjugate complexes and their use
US8865674B2 (en) 2011-09-20 2014-10-21 Isis Pharmaceuticals, Inc. Antisense modulation of GCGR expression
BR112014009790A2 (en) 2011-10-25 2018-05-15 Isis Pharmaceuticals Inc compound for antisense modulation of gccr expression, its use and composition
EP3650544A1 (en) 2011-11-07 2020-05-13 Ionis Pharmaceuticals, Inc. Modulation of tmprss6 expression
DK2794880T3 (en) 2011-12-22 2018-07-23 Ionis Pharmaceuticals Inc METHOD OF MODULATING METASTASE-ASSOCIATED-IN-LONG-ADENOCARCINOM TRANSCRIPT-1- (MALATE-1) EXPRESSION
EP2802674B1 (en) 2012-01-11 2020-12-16 Ionis Pharmaceuticals, Inc. Compositions and methods for modulation of ikbkap splicing
WO2013120003A1 (en) 2012-02-08 2013-08-15 Isis Pharmaceuticals, Inc. Modulation of rna by repeat targeting
US8837096B2 (en) 2012-03-13 2014-09-16 Thoratec Corporation Fault monitor for fault tolerant implantable pump
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
EP2850092B1 (en) 2012-04-09 2017-03-01 Ionis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
WO2013159108A2 (en) 2012-04-20 2013-10-24 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising bicyclic nucleotides and uses thereof
US9518261B2 (en) 2012-05-22 2016-12-13 Ionis Pharmaceuticals, Inc. Modulation of enhancer RNA mediated gene expression
EP2855500B1 (en) 2012-05-24 2020-07-01 Ionis Pharmaceuticals, Inc. Methods and compositions for modulating apolipoprotein(a) expression
PL3461895T3 (en) 2012-06-25 2021-01-11 Ionis Pharmaceuticals, Inc. Modulation of ube3a-ats expression
EP2877579B1 (en) 2012-07-27 2019-12-18 Ionis Pharmaceuticals, Inc. Modulation of renin-angiotensin system (ras) related diseases by angiotensinogen
EP2885312B1 (en) 2012-08-15 2025-09-03 Ionis Pharmaceuticals, Inc. Method of preparing oligomeric compounds using modified capping protocols
US9993522B2 (en) 2012-09-18 2018-06-12 Uti Limited Partnership Treatment of pain by inhibition of USP5 de-ubiquitinase
US9175291B2 (en) 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
WO2014059364A1 (en) 2012-10-11 2014-04-17 Isis Pharmaceuticals, Inc. Methods of treating kennedy's disease
WO2014059356A2 (en) 2012-10-12 2014-04-17 Isis Pharmaceuticals, Inc. Selective antisense compounds and uses thereof
EP4144845B1 (en) 2012-10-12 2024-04-24 Ionis Pharmaceuticals, Inc. Antisense compounds and uses thereof
DK2906696T4 (en) 2012-10-15 2023-02-27 Ionis Pharmaceuticals Inc METHODS OF MODULATING C9ORF72 EXPRESSION
MX365158B (en) 2012-10-31 2019-05-24 Ionis Pharmaceuticals Inc Cancer treatment.
CN117126846A (en) 2012-11-15 2023-11-28 罗氏创新中心哥本哈根有限公司 Oligonucleotide conjugates
DK2922955T3 (en) 2012-11-26 2019-05-13 Roche Innovation Ct Copenhagen As Compositions and Methods for Modulating FGFR3 Expression
US8968174B2 (en) 2013-01-16 2015-03-03 Thoratec Corporation Motor fault monitor for implantable blood pump
US9371826B2 (en) 2013-01-24 2016-06-21 Thoratec Corporation Impeller position compensation using field oriented control
WO2014118272A1 (en) 2013-01-30 2014-08-07 Santaris Pharma A/S Antimir-122 oligonucleotide carbohydrate conjugates
CA2893801A1 (en) 2013-01-30 2014-08-07 F. Hoffmann-La Roche Ag Lna oligonucleotide carbohydrate conjugates
CA2899924A1 (en) 2013-02-04 2014-08-07 Isis Pharmaceuticals, Inc. Selective antisense compounds and uses thereof
KR102169899B1 (en) 2013-02-14 2020-10-26 아이오니스 파마수티컬즈, 인코포레이티드 Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations
US9556873B2 (en) 2013-02-27 2017-01-31 Tc1 Llc Startup sequence for centrifugal pump with levitated impeller
US10398661B2 (en) 2013-02-28 2019-09-03 The Board Of Regents Of The University Of Texas System Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
DE102013102194A1 (en) * 2013-03-06 2014-09-11 Werner Eck Drive device for a moving in a fluid vehicle
WO2014153236A1 (en) 2013-03-14 2014-09-25 Isis Pharmaceuticals, Inc. Compositions and methods for modulating tau expression
US10052420B2 (en) 2013-04-30 2018-08-21 Tc1 Llc Heart beat identification and pump speed synchronization
DK2991656T3 (en) 2013-05-01 2020-03-23 Ionis Pharmaceuticals Inc COMPOSITIONS AND PROCEDURES FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
US9909124B2 (en) 2013-06-21 2018-03-06 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile
EP3564374A1 (en) 2013-06-21 2019-11-06 Ionis Pharmaceuticals, Inc. Compositions and methods for modulation of target nucleic acids
SG11201510656PA (en) 2013-06-27 2016-01-28 Roche Innovation Ct Copenhagen As Antisense oligomers and conjugates targeting pcsk9
RU2700244C2 (en) 2013-07-02 2019-09-13 Ионис Фармасьютикалз, Инк. Modulators of growth hormone receptor
TW202246503A (en) 2013-07-19 2022-12-01 美商百健Ｍａ公司 Compositions for modulating tau expression
US10435430B2 (en) 2013-07-31 2019-10-08 Ionis Pharmaceuticals, Inc. Methods and compounds useful in conditions related to repeat expansion
HRP20200250T1 (en) 2013-08-08 2020-05-29 The Scripps Research Institute SITE-SPECIFIC ENZYME MARKING OF NUCLEIC ACIDS AND IN VITRO IMPLEMENTATION OF NON-NATURAL NUCLEOTIDS
TW201536329A (en) 2013-08-09 2015-10-01 Isis Pharmaceuticals Inc Compound and method for regulating the manifestation of dystrophic myotonic protein kinase (DMPK)
JP6652922B2 (en) 2013-08-28 2020-02-26 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Regulation of prekallikrein (PKK) expression
US20160222389A1 (en) 2013-09-13 2016-08-04 Ionis Pharmaceuticals, Inc. Modulators of complement factor b
WO2015042447A1 (en) 2013-09-20 2015-03-26 Isis Pharmaceuticals, Inc. Targeted therapeutic nucleosides and their use
SG10201808903UA (en) 2013-10-11 2018-11-29 Ionis Pharmaceuticals Inc Compositions for modulating c9orf72 expression
US9239345B2 (en) 2013-11-20 2016-01-19 Woodward, Inc. Controlling a motor with two or more Hall sensors
ES2797679T3 (en) 2013-12-02 2020-12-03 Ionis Pharmaceuticals Inc Antisense compounds and their uses
US20170037409A1 (en) 2013-12-24 2017-02-09 Ionis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
US10988030B2 (en) 2014-09-26 2021-04-27 Francis Xavier Gentile Electric motor, generator and battery combination
RU2019130898A (en) 2014-03-19 2019-11-11 Ионис Фармасьютикалз, Инк. COMPOSITIONS FOR MODULATION OF ATAXIN 2 EXPRESSION
SG10201910844SA (en) 2014-04-01 2020-01-30 Biogen Ma Inc Compositions for modulating sod-1 expression
TWI638047B (en) 2014-04-09 2018-10-11 史基普研究協會 Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
WO2015164693A1 (en) 2014-04-24 2015-10-29 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
EP3137476B1 (en) 2014-04-28 2019-10-09 Ionis Pharmaceuticals, Inc. Linkage modified oligomeric compounds
EP3137115B1 (en) 2014-05-01 2020-10-14 Ionis Pharmaceuticals, Inc. Method for synthesis of reactive conjugate clusters
WO2015168532A2 (en) 2014-05-01 2015-11-05 Isis Pharmaceuticals, Inc. Compositions and methods for modulating pkk expression
US10570169B2 (en) 2014-05-22 2020-02-25 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
US9623161B2 (en) 2014-08-26 2017-04-18 Tc1 Llc Blood pump and method of suction detection
US10822369B2 (en) 2014-11-14 2020-11-03 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of proteins
US10364433B2 (en) 2014-11-14 2019-07-30 The Regents Of The University Of California Modulation of AGPAT5 expression
CN105634225B (en) * 2014-11-26 2020-10-09 德昌电机(深圳)有限公司 Brushless DC motor and electric power steering system using the same
US9517270B2 (en) 2014-12-08 2016-12-13 The Board Of Regents Of The University Of Texas System Lipocationic polymers and uses thereof
AU2015364508A1 (en) 2014-12-18 2017-07-06 Alnylam Pharmaceuticals, Inc. ReversirTM compounds
CN104617827B (en) * 2015-02-02 2017-05-31 东南大学 A kind of axial magnetic field flux switch permanent magnet motor fault tolerant control method used for electric vehicle
EP3256183B1 (en) 2015-02-11 2025-08-13 Tc1 Llc Heart beat identification and pump speed synchronization
US10371152B2 (en) 2015-02-12 2019-08-06 Tc1 Llc Alternating pump gaps
WO2016130944A1 (en) 2015-02-12 2016-08-18 Thoratec Corporation System and method for controlling the position of a levitated rotor
US10245361B2 (en) 2015-02-13 2019-04-02 Tc1 Llc Impeller suspension mechanism for heart pump
BR112017017178A2 (en) 2015-02-26 2018-04-03 Ionis Pharmaceuticals Inc p23h rhodopsin allele-specific modulators
US20180044673A1 (en) 2015-03-03 2018-02-15 Ionis Pharmaceuticals, Inc. Methods for modulating mecp2 expression
EP4636085A3 (en) 2015-03-03 2026-01-07 Ionis Pharmaceuticals, Inc. Compositions for modulating mecp2 expression
AU2016285724A1 (en) 2015-06-29 2017-11-16 Ionis Pharmaceuticals, Inc. Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
AU2016294347B2 (en) 2015-07-10 2022-07-28 Ionis Pharmaceuticals, Inc. Modulators of diacyglycerol acyltransferase 2 (DGAT2)
EP3324980B1 (en) 2015-07-17 2021-11-10 Alnylam Pharmaceuticals, Inc. Multi-targeted single entity conjugates
DK3349802T3 (en) 2015-09-14 2021-10-11 Univ Texas Lipocationic dendrimers and uses thereof
RU2018113709A (en) 2015-09-24 2019-10-30 Айонис Фармасьютикалз, Инк. KRAS EXPRESSION MODULATORS
US10117983B2 (en) 2015-11-16 2018-11-06 Tc1 Llc Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device
US11761007B2 (en) 2015-12-18 2023-09-19 The Scripps Research Institute Production of unnatural nucleotides using a CRISPR/Cas9 system
CN109414408B (en) 2016-05-16 2022-03-29 得克萨斯州大学系统董事会 Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
US20190218257A1 (en) 2016-06-24 2019-07-18 The Scripps Research Institute Novel nucleoside triphosphate transporter and uses thereof
US11148819B2 (en) 2019-01-23 2021-10-19 H55 Sa Battery module for electrically-driven aircraft
US11063323B2 (en) 2019-01-23 2021-07-13 H55 Sa Battery module for electrically-driven aircraft
US10479223B2 (en) 2018-01-25 2019-11-19 H55 Sa Construction and operation of electric or hybrid aircraft
US11065979B1 (en) 2017-04-05 2021-07-20 H55 Sa Aircraft monitoring system and method for electric or hybrid aircrafts
US10854866B2 (en) 2019-04-08 2020-12-01 H55 Sa Power supply storage and fire management in electrically-driven aircraft
US12409756B2 (en) 2017-04-05 2025-09-09 H55 Sa Aircraft monitoring system and method for electric or hybrid aircrafts
WO2019014262A1 (en) 2017-07-11 2019-01-17 The Scripps Research Institute Incorporation of unnatural nucleotides and methods of use in vivo thereof
IL322312A (en) 2017-08-03 2025-09-01 Synthorx Inc Cytokine conjugates for the treatment of proliferative and infectious diseases
CA3091857A1 (en) 2018-02-26 2019-08-29 Synthorx, Inc. Il-15 conjugates and uses thereof
MX2020011570A (en) 2018-05-07 2020-11-24 Alnylam Pharmaceuticals Inc Extrahepatic delivery.
AU2019350765A1 (en) 2018-09-28 2021-05-27 Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated ocular diseases
CA3127689A1 (en) 2019-02-06 2020-08-13 Synthorx, Inc. Il-2 conjugates and methods of use thereof
JP7667074B2 (en) 2019-03-29 2025-04-22 田辺三菱製薬株式会社 Compounds, methods and pharmaceutical compositions for modulating DUX4 expression
EP3969052A1 (en) 2019-05-17 2022-03-23 Alnylam Pharmaceuticals Inc. Oral delivery of oligonucleotides
KR20220047598A (en) 2019-08-15 2022-04-18 신톡스, 인크. Immuno-oncology Combination Therapy Using IL-2 Conjugates
CA3148135A1 (en) 2019-08-23 2021-03-04 Carolina E. CAFFARO Il-15 conjugates and uses thereof
CN114746122A (en) 2019-09-10 2022-07-12 新索思股份有限公司 IL-2 conjugates and methods of use to treat autoimmune diseases
TWI891672B (en) 2019-11-04 2025-08-01 美商欣爍克斯公司 Interleukin 10 conjugates and uses thereof
CA3160329A1 (en) 2019-11-06 2021-05-14 Alnylam Pharmaceuticals, Inc. Extrahepatic delivery
EP4055165A1 (en) 2019-11-06 2022-09-14 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
EP4151237A4 (en) 2020-05-12 2024-08-14 Mitsubishi Tanabe Pharma Corporation COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING ATAXY-3 EXPRESSION
MX2022016254A (en) 2020-06-25 2023-04-11 Synthorx Inc Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies.
US20230257745A1 (en) 2020-07-10 2023-08-17 Alnylam Pharmaceuticals, Inc. Circular siRNAs
TW202228785A (en) 2020-10-09 2022-08-01 美商欣爍克斯公司 Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
AU2021356610A1 (en) 2020-10-09 2023-06-15 Synthorx, Inc. Immuno oncology therapies with il-2 conjugates
CA3196205A1 (en) 2020-10-23 2022-04-28 Floyd E. Romesberg Reverse transcription of polynucleotides comprising unnatural nucleotides
CR20230308A (en) 2020-12-11 2023-09-08 Civi Biopharma Inc ORAL DELIVERY OF ANTISENSE CONJUGATES TARGETTING PCSK9
WO2022147223A2 (en) 2020-12-31 2022-07-07 Alnylam Pharmaceuticals, Inc. 2'-modified nucleoside based oligonucleotide prodrugs
AU2021411579A1 (en) 2020-12-31 2023-07-13 Alnylam Pharmaceuticals, Inc. Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
EP4291243A1 (en) 2021-02-12 2023-12-20 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
TW202245843A (en) 2021-02-12 2022-12-01 美商欣爍克斯公司 Skin cancer combination therapy with il-2 conjugates and cemiplimab
IL307298A (en) 2021-03-31 2023-11-01 Entrada Therapeutics Inc Cyclic cell penetrating peptides
KR20240012425A (en) 2021-05-10 2024-01-29 엔트라다 테라퓨틱스, 인크. Compositions and methods for intracellular therapeutics
WO2022240721A1 (en) 2021-05-10 2022-11-17 Entrada Therapeutics, Inc. Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity
US20250051780A1 (en) 2021-05-10 2025-02-13 Entrada Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICING
US11682997B2 (en) 2021-05-17 2023-06-20 Hitachi Astemo Americas, Inc. Rotary electric machine with selectable coil control
TW202313117A (en) 2021-06-03 2023-04-01 美商欣爍克斯公司 Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab
KR20240038967A (en) 2021-06-23 2024-03-26 엔트라다 테라퓨틱스, 인크. Antisense compounds and methods for targeting CUG repeats
WO2023283403A2 (en) 2021-07-09 2023-01-12 Alnylam Pharmaceuticals, Inc. Bis-rnai compounds for cns delivery
MX2024000981A (en) 2021-07-21 2024-02-12 Alnylam Pharmaceuticals Inc Metabolic disorder-associated target gene irna compositions and methods of use thereof.
KR20240082344A (en) 2021-09-01 2024-06-10 엔트라다 테라퓨틱스, 인크. Compounds and methods for skipping exon 44 in Duchenne muscular dystrophy
KR20240101590A9 (en) 2021-10-15 2025-12-10 알닐람 파마슈티칼스 인코포레이티드 Extrahepatic delivery IRNA composition and method of using the same
US20250019702A1 (en) 2021-11-10 2025-01-16 University Of Rochester Gata4-targeted therapeutics for treatment of cardiac hypertrophy
CA3237770A1 (en) 2021-11-10 2023-05-19 University Of Rochester Antisense oligonucleotides for modifying protein expression
JP2025501682A (en) 2021-12-03 2025-01-23 クラリス コーポレーション Gapmer antisense oligonucleotides with modified backbone chemistry - Patent Application 20070229933
WO2023122573A1 (en) 2021-12-20 2023-06-29 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
JP2025516680A (en) 2022-05-13 2025-05-30 アルナイラム ファーマシューティカルズ， インコーポレイテッド Single-stranded loop oligonucleotide
WO2024006999A2 (en) 2022-06-30 2024-01-04 Alnylam Pharmaceuticals, Inc. Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
WO2024039776A2 (en) 2022-08-18 2024-02-22 Alnylam Pharmaceuticals, Inc. Universal non-targeting sirna compositions and methods of use thereof
JP2025530741A (en) 2022-08-29 2025-09-17 ユニヴァーシティ オヴ ロチェスター Antisense oligonucleotide-based antifibrotic therapeutic agents
JP2025532985A (en) 2022-09-30 2025-10-03 アルナイラム ファーマシューティカルズ， インコーポレイテッド Modified double-stranded RNA agents
WO2024136899A1 (en) 2022-12-21 2024-06-27 Synthorx, Inc. Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies
CN120813691A (en) 2023-02-09 2025-10-17 阿尔尼拉姆医药品有限公司 REVERSIR molecules and methods of use thereof
WO2024196937A1 (en) 2023-03-20 2024-09-26 Synthorx, Inc. Cancer therapy with il-2 peg conjugates
WO2024216155A1 (en) 2023-04-12 2024-10-17 Alnylam Pharmaceuticals, Inc. Extrahepatic delivery of double-stranded rna agents
WO2024238385A2 (en) 2023-05-12 2024-11-21 Alnylam Pharmaceuticals, Inc. Single-stranded loop oligonucleotides
WO2025064660A2 (en) 2023-09-21 2025-03-27 Alnylam Pharmaceuticals, Inc. Activin a receptor type 1c (acvr1c) irna compositions and methods of use thereof
WO2025080939A1 (en) 2023-10-13 2025-04-17 Ultragenyx Pharmaceutical, Inc. Compositions and methods for treating conditions associated with cartilage oligomeric matrix protein (comp) mutations
WO2025128853A2 (en) 2023-12-13 2025-06-19 Ultragenyx Pharmaceutical Inc. Compositions and methods for treating conditions associated with ube3a overexpression
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
WO2025207517A2 (en) 2024-03-25 2025-10-02 Synthorx, Inc. Synthetic trna synthetases and cells comprising synthetic molecules for production of polypeptides
GB202404290D0 (en) 2024-03-26 2024-05-08 Senisca Ltd Novel oligoncleotides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809990A (en) * 1972-07-27 1974-05-07 Warner Electric Brake & Clutch Electric motor adapted for both stepping and continuous operation
US4434389A (en) * 1980-10-28 1984-02-28 Kollmorgen Technologies Corporation Motor with redundant windings
FR2541529A1 (en) * 1983-02-18 1984-08-24 Sundstrand Corp MULTI-CHANNEL ELECTROMOTOR MACHINE

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9414226A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108945485A (en) * 2017-05-17 2018-12-07 通用电气公司 Propulsion system for aircraft

Also Published As

Publication number Publication date
RU95114435A (en) 1997-05-20
WO1994014226A1 (en) 1994-06-23
JPH08504559A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
EP0673559A1 (en) Motor system with individually controlled redundant windings
US5990643A (en) Sensorless commutation position detection for brushless D.C. motors
US8084972B2 (en) Dual lane control of a permanent magnet brushless motor using non-trapezoidal commutation control
EP0923802B1 (en) Permanent magnet direct current (pmdc) machine with integral reconfigurable winding control
CN101490926B (en) Electric motor
US4565956A (en) Fast-acting servo drive system
EP1588481A2 (en) Phase advance angle optimization for brushless motor control
WO1992020135A1 (en) Torque driven dual pmg actuator
KR101290888B1 (en) Power supply device for an electric motor method for operation of an electric motor
WO1992020131A2 (en) Axial gap dual permanent magnet generator
WO2009110206A1 (en) Brushless motor device and control device
US5113824A (en) Adjusting device
US4454458A (en) Synchronous drive for brushless DC motor
US6646851B1 (en) Circuit arrangement for operating a solenoid actuator
US4963800A (en) Apparatus for controlling throttle actuator
US4986614A (en) Motor-driven antilock brake pressure modulator having differential motor performance characteristics
CN105703590A (en) reluctance motor with virtual rotor
US6573672B2 (en) Fail passive servo controller
US6953013B2 (en) Valve timing controller
EP3346600B1 (en) High efficiency actuator for use in a momentum control device
EP1429449B1 (en) Torque stabilizer for brushless servo motor
US4799002A (en) Method of driving a five-phase stepping motor
Adhul et al. Control electronics module for flow control valve using FPGA
US5783920A (en) Error signal control circuit for a phase-lock-loop sensorless motor controller
WO2008103630A1 (en) Adjusting commutation of a brusheless dc motor to increase motor speed

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950523

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 19951107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960301